14-102434309-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014844.5(TECPR2):​c.1492C>A​(p.Gln498Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,292,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000031 ( 0 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 1.86
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07631314).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TECPR2NM_014844.5 linkuse as main transcriptc.1492C>A p.Gln498Lys missense_variant 9/20 ENST00000359520.12
TECPR2NM_001172631.3 linkuse as main transcriptc.1492C>A p.Gln498Lys missense_variant 9/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TECPR2ENST00000359520.12 linkuse as main transcriptc.1492C>A p.Gln498Lys missense_variant 9/201 NM_014844.5 P1O15040-1
TECPR2ENST00000558678.1 linkuse as main transcriptc.1492C>A p.Gln498Lys missense_variant 9/171 O15040-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000310
AC:
4
AN:
1292212
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
626080
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000392
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000292
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 49 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 26, 2022This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 498 of the TECPR2 protein (p.Gln498Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TECPR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473088). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.May 31, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0029
T;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.83
T;T
M_CAP
Benign
0.0032
T
MetaRNN
Benign
0.076
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;M
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.59
N;N
REVEL
Benign
0.030
Sift
Benign
0.15
T;T
Sift4G
Benign
0.75
T;T
Polyphen
0.16
B;.
Vest4
0.15
MutPred
0.23
Gain of ubiquitination at Q498 (P = 0.0011);Gain of ubiquitination at Q498 (P = 0.0011);
MVP
0.068
MPC
0.40
ClinPred
0.11
T
GERP RS
4.5
Varity_R
0.098
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1018872661; hg19: chr14-102900646; API